MedPath

The effect of pre-emptive intravenous ondansetron on patients presented to elective C.S under combined spinal-epidural anesthesia

Not Applicable
Conditions
Circulatory System
Anaesthesia
Registration Number
PACTR201809811205627
Lead Sponsor
tanta university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
60
Inclusion Criteria

60 Patients
presented for elective cesarean sections
American Society of Anesthesiologists (ASA) patient status classification II
ages 21-40 years

Exclusion Criteria

1. Age younger than 21 or older than 40 years
2. Major cardiovascular diseases
3. Preexisting hypertension or gestational hypertension, preeclampsia
4. Body mass index greater than 35 kg/m2.
5. Emesis gravidarum
6. Contraindication to neuraxial anesthesia (patient refusal, unstable hemodynamic, and coagulation abnormalities)
7. Any study drugs allergy.
8. emergent cesarean sections, multiple parities (twins/triplets)
9. > 1,000 ml blood loss,

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of hypotension will be collected at pre-defined time points: baseline measurement while supine (T0), in the sitting position (T1), immediately after injection of spinal anesthesia (T2), 5 and 10 min after spinal anesthesia while supine (T3, T4), at skin incision (T5), 3 min after skin incision (T6), at newborn delivery (T7), 3 min after delivery (T8), 10 min after delivery (T9) and at the end of surgery (T10).
Secondary Outcome Measures
NameTimeMethod
changes in the heart rate will be collected at pre-defined time points: baseline measurement while supine (T0), in the sitting position (T1), immediately after injection of spinal anesthesia (T2), 5 and 10 min after spinal anesthesia while supine (T3, T4), at skin incision (T5), 3 min after skin incision (T6), at newborn delivery (T7), 3 min after delivery (T8), 10 min after delivery (T9) and at the end of surgery (T10). and the effect of the APGAR score.
© Copyright 2025. All Rights Reserved by MedPath